Yahoo Web Search

Search results

1. www.nature.com › articles › s44324/024/00014-5Finishing the odyssey to a stem cell cure for type 1 diabetes

   www.nature.com › articles › s44324/024/00014-5

   4 days ago · Rationale for stem cell therapies in T1D. The autoimmune destruction of pancreatic β cells creates a lifelong dependence on insulin to control blood sugar levels in individuals with type 1 ...

2. www.sciencedaily.com › news › health_medicineStem Cells News -- ScienceDaily

   www.sciencedaily.com › news › health_medicine

   • Cached

   1 day ago · July 9, 2024 — New research shows how stem cell-derived therapy, targeting treatment-resistant liver cancer through genetically modified NK cells, offers promising new avenues for ... Latest...

3. www.managedhealthcareexecutive.com › view › new-study-showsNew Study Shows Short-Term Benefits of Stem Cell Therapy for MS...

   www.managedhealthcareexecutive.com › view › new-study-shows

   • Cached

   4 days ago · From the data, it was determined that stem cell therapy significantly improved MS patients expanded disability status scale following two months, and reduced brain lesion volume during the first two months as well. Therefore, the team concluded stem cell therapy does improve the disability of MS patients and reduce their brain lesion volume.

4. medicalxpress.com › news › 2024-07-immune-cell-stem-transplantImmune cell transformation can influence stem cell transplant...

   medicalxpress.com › news › 2024-07-immune-cell-stem-transplant

   • Cached

   1 day ago · The finding appeared July 17, 2024, in Nature Communications.. In the U.S., there have been more than 8,000 allogeneic stem cell transplants performed annually over the past decade or so.

5. biosignaling.biomedcentral.com › articles › 10Advancing stroke therapy: innovative approaches with stem...

   biosignaling.biomedcentral.com › articles › 10

   • Cached

   4 days ago · Stroke is a leading cause of mortality and long-term disability globally, with acute ischemic stroke (AIS) being the most common subtype. Despite significant advances in reperfusion therapies, their limited time window and associated risks underscore the necessity for novel treatment strategies. Stem cell-derived extracellular vesicles (EVs) have emerged as a promising therapeutic approach due ...

6. www.nature.com › subjects › induced-pluripotent-stem-cellsInduced pluripotent stem cells - Latest research and news -...

   www.nature.com › subjects › induced-pluripotent-stem-cells

   4 days ago · This Review explores the principles and applications of cell purification technologies, with a particular emphasis on their clinical relevance for pluripotent stem-cell-based therapies.

7. www.thelancet.com › journals › lanhaeBrentuximab vedotin plus cyclophosphamide, doxorubicin,...

   www.thelancet.com › journals › lanhae

   2 days ago · Brentuximab vedotin consolidation after autologous stem-cell transplantation or directly after induction therapy was feasible, although a high rate of neuropathy was observed. The outcomes we observed in a cohort comprised mostly of people with peripheral T-cell lymphoma subtypes other than anaplastic large-cell lymphoma suggest that further evaluation of this approach is warranted.